Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriele Neumann

Showing results (51-60 of 186) with videos related to

Pageof 19
Sort By:
Viruses|April 23, 2022
Characterization of H9N2 Avian Influenza Viruses Isolated from Poultry Products in a Mouse ModelJurika Murakami, Akihiro Shibata, Gabriele Neumann, et al.
Vaccine|July 3, 2017
M2SR, a novel live influenza vaccine, protects mice and ferrets against highly pathogenic avian influenzaYasuko Hatta, David Boltz, Sally Sarawar, et al.
Viruses|July 27, 2022
Influenza Viruses Suitable for Studies in Syrian HamstersShufang Fan, Chunyang Gu, Huihui Kong, et al.
Mbio|December 7, 2021
H3N2 Influenza Viruses with 12- or 16-Amino Acid Deletions in the Receptor-Binding Region of Their Hemagglutinin ProteinHuihui Kong, Shufang Fan, Kosuke Takada, et al.
Vaccine|July 16, 2018
Novel influenza vaccine M2SR protects against drifted H1N1 and H3N2 influenza virus challenge in ferrets with pre-existing immunityYasuko Hatta, David Boltz, Sally Sarawar, et al.
Journal of Virology|February 18, 2011
Impact of amino acid mutations in PB2, PB1-F2, and NS1 on the replication and pathogenicity of pandemic (H1N1) 2009 influenza virusesMakoto Ozawa, Sarmila Basnet, Lisa M Burley, et al.
The Journal of General Virology|December 18, 2009
Role of host-specific amino acids in the pathogenicity of avian H5N1 influenza viruses in miceJin Hyun Kim, Masato Hatta, Shinji Watanabe, et al.
Lancet (London, England)|April 29, 2008
Human infection with highly pathogenic H5N1 influenza virusAndrea Gambotto, Simon M Barratt-Boyes, Menno D de Jong, et al.
Plos Pathogens|November 21, 2012
Egyptian H5N1 influenza viruses-cause for concern?Gabriele Neumann, Catherine A Macken, Alexander I Karasin, et al.
Journal of Virology|May 14, 2005
Live bivalent vaccine for parainfluenza and influenza virus infectionsYasuko Maeda, Masato Hatta, Ayato Takada, et al.
Pageof 19

Showing results (51-60 of 186) with videos related to

Sort By:
Pageof 19
Viruses|April 23, 2022
Characterization of H9N2 Avian Influenza Viruses Isolated from Poultry Products in a Mouse ModelJurika Murakami, Akihiro Shibata, Gabriele Neumann, et al.
Vaccine|July 3, 2017
M2SR, a novel live influenza vaccine, protects mice and ferrets against highly pathogenic avian influenzaYasuko Hatta, David Boltz, Sally Sarawar, et al.
Viruses|July 27, 2022
Influenza Viruses Suitable for Studies in Syrian HamstersShufang Fan, Chunyang Gu, Huihui Kong, et al.
Mbio|December 7, 2021
H3N2 Influenza Viruses with 12- or 16-Amino Acid Deletions in the Receptor-Binding Region of Their Hemagglutinin ProteinHuihui Kong, Shufang Fan, Kosuke Takada, et al.
Vaccine|July 16, 2018
Novel influenza vaccine M2SR protects against drifted H1N1 and H3N2 influenza virus challenge in ferrets with pre-existing immunityYasuko Hatta, David Boltz, Sally Sarawar, et al.
Journal of Virology|February 18, 2011
Impact of amino acid mutations in PB2, PB1-F2, and NS1 on the replication and pathogenicity of pandemic (H1N1) 2009 influenza virusesMakoto Ozawa, Sarmila Basnet, Lisa M Burley, et al.
The Journal of General Virology|December 18, 2009
Role of host-specific amino acids in the pathogenicity of avian H5N1 influenza viruses in miceJin Hyun Kim, Masato Hatta, Shinji Watanabe, et al.
Lancet (London, England)|April 29, 2008
Human infection with highly pathogenic H5N1 influenza virusAndrea Gambotto, Simon M Barratt-Boyes, Menno D de Jong, et al.
Plos Pathogens|November 21, 2012
Egyptian H5N1 influenza viruses-cause for concern?Gabriele Neumann, Catherine A Macken, Alexander I Karasin, et al.
Journal of Virology|May 14, 2005
Live bivalent vaccine for parainfluenza and influenza virus infectionsYasuko Maeda, Masato Hatta, Ayato Takada, et al.
Pageof 19